InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Browse the complete record of transactions filed by Kirby John J., 首席财务官. Insider active across 2 companies, notably Idera Pharmaceuticals, INC.. Aggregated, 6 disclosures have been logged. Breakdown: 3 buys · 0 sell. Total volume traded: €40k. History available since 17 December 2021. The latest transaction was filed on 18 August 2026 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Kirby John J. is Chief Financial Officer and has been reported in 6 filings. Among the 6 sampled filings, the transactions are acquisitions, totaling EUR 39724, with filings dated from 2021-12-21 to 2026-08-18 at Verrica Pharmaceuticals Inc. and Idera Pharmaceuticals, INC.